A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Scientia Clinical Research, Randwick

Rigshospitalet, Copenhagen

Macquarie University Hospital, Macquarie University

The Alfred Hospital, Melbourne

Odense University Hospital, Odense

Linear Clinical Research Ltd, Nedlands

Icahn School of Medicine at Mount Sinai, New York

Memorial Sloan Kettering Cancer Center, New York

Institut Universitaire du cancer de Toulouse-Oncopole, Toulouse

Carmel Medical Center, Haifa

Sarah Cannon Research Institute, Nashville

CHRU de Lille Hopital Claude Huriez, Lille

Tel Aviv Sourasky Medical Center, Tel Aviv

Institut de Cancerologie Strasbourg Europe ICANS, Strasbourg

Institut Curie, Paris

The University of Texas MD Anderson Cancer Center, Houston

Texas Transplant Institute, San Antonio

City of Hope, Duarte

Seattle Cancer Care Alliance, Seattle

Tianjin cancer hospital, Tianjin

Chongqing University Cancer Hospital, Chongqing

Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan

Sun Yat Sen University Cancer Center, Guangzhou

Hadassah Medical Center, Jerusalem

National Cancer Center Hospital East, Kashiwa

Aichi Cancer Center, Nagoya

The Cancer Institute Hospital of JFCR, Tokyo

Uniwersyteckie Centrum Kliniczne Osrodek Badan Klinicznych Wczesnych Faz, Gdansk

Aidport Sp z o o, Skorzewo